Kasatkar P - Search Results

1

JAK2 mutations across a spectrum of venous thrombosis cases.

Shetty S, Kulkarni B, Pai N, Mukundan P, Kasatkar P, Ghosh K. Shetty S, et al. Among authors: kasatkar p. Am J Clin Pathol. 2010 Jul;134(1):82-5. doi: 10.1309/AJCP7VO4HAIZYATP. Am J Clin Pathol. 2010. PMID: 20551270

2

Genetic heterogeneity in a large cohort of Indian type 3 von Willebrand disease patients.

Kasatkar P, Shetty S, Ghosh K. Kasatkar P, et al. PLoS One. 2014 Mar 27;9(3):e92575. doi: 10.1371/journal.pone.0092575. eCollection 2014. PLoS One. 2014. PMID: 24675615 Free PMC article.

3

The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles: a rebuttal.

Kasatkar P, Ghosh K, Shetty S. Kasatkar P, et al. J Thromb Haemost. 2013 Sep;11(9):1784-5. doi: 10.1111/jth.12323. J Thromb Haemost. 2013. PMID: 23773799 Free article. No abstract available.

4

Additional markers for genetic diagnosis of type 3 von Willebrand disease in Indian population.

Kasatkar P, Ghosh K, Shetty S. Kasatkar P, et al. Indian J Med Res. 2015 Dec;142(6):759-62. doi: 10.4103/0971-5916.174570. Indian J Med Res. 2015. PMID: 26831425 Free PMC article. No abstract available.

5

Delayed vitamin K deficiency as a cause of bleeding: still a concern in the 21st century!

Kasatkar P, Shetty S, Ghosh K. Kasatkar P, et al. Blood Coagul Fibrinolysis. 2010 Sep;21(6):608-10. doi: 10.1097/MBC.0b013e32833b645c. Blood Coagul Fibrinolysis. 2010. PMID: 20531166

6

The Epidemiology of FVIII Inhibitors in Indian Haemophilia A Patients.

Pinto P, Shelar T, Nawadkar V, Mirgal D, Mukaddam A, Nair P, Kasatkar P, Gaikwad T, Ali S, Jadli A, Patil R, Parihar A, Shanbhag S, Kulkarni B, Ghosh K, Shetty S. Pinto P, et al. Among authors: kasatkar p. Indian J Hematol Blood Transfus. 2014 Dec;30(4):356-63. doi: 10.1007/s12288-014-0342-z. Epub 2014 Feb 5. Indian J Hematol Blood Transfus. 2014. PMID: 25435742 Free PMC article.

7

Sense, missense, and nonsense: a novel mechanism of premature termination codon (PTC) mutation in a severe von Willebrand disease (VWD) patient.

Kasatkar P, Kulkarni B, Ghosh K, Shetty S. Kasatkar P, et al. Ann Hematol. 2015 Aug;94(8):1409-10. doi: 10.1007/s00277-015-2373-4. Epub 2015 Apr 15. Ann Hematol. 2015. PMID: 25869031 No abstract available.

8

Pathophysiology of acquired von Willebrand disease: a concise review.

Shetty S, Kasatkar P, Ghosh K. Shetty S, et al. Among authors: kasatkar p. Eur J Haematol. 2011 Aug;87(2):99-106. doi: 10.1111/j.1600-0609.2011.01636.x. Eur J Haematol. 2011. PMID: 21535159 Review.

9

An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE).

Kasatkar P, Ghosh K, Shetty S. Kasatkar P, et al. Ann Hematol. 2014 Jan;93(1):173-5. doi: 10.1007/s00277-013-1767-4. Epub 2013 Apr 27. Ann Hematol. 2014. PMID: 23625134 No abstract available.

10

Prenatal diagnosis in severe von Willebrand disease families from India using combination of phenotypic and genotypic assays.

Kasatkar P, Shetty S, Ghosh K. Kasatkar P, et al. Prenat Diagn. 2014 Apr;34(4):377-81. doi: 10.1002/pd.4315. Epub 2014 Jan 28. Prenat Diagn. 2014. PMID: 24390653

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results